Skip to content
Screener

The Cooper Companies, Inc. COO Financing Cash Flow

Financing Cash Flow at other companies

Baxter International logo
Baxter InternationalBAX
-$11M+99.7%
Revvity logo
RevvityRVTY
-$88.9M+45.7%
Johnson & Johnson logo
Johnson & JohnsonJNJ
-$8.78B-54.9%
Utah Medical Products logo
Utah Medical ProductsUTMD
-$1.12M+73.6%
AbbVie logo
AbbVieABBV
$919M+173%
Medtronic logo
MedtronicMDT
-$888M+33.9%

Other financials

Income statement

See full
Revenue$1.1B+7.9%
Gross profit$735.4M+8.3%
Operating income-$31.0M-117%
Net income-$77.9M-189%
EPS (diluted)-$0.40-191%

Balance sheet

See full
Cash & equivalents$139.0M+19.6%
Total debt$3.1B+15.6%
Total equity$8.2B-0.6%
Total assets$12.5B+0.6%

Cash flow

See full
Operating cash flow$182.8M+90.0%
CapEx$86.4M+10.6%
Free cash flow$96.4M+433%

Valuation

See full
Market cap$14.6B+7.4%
Enterprise value$17.52B+9.5%
P/E61.9×+28.6×
P/S3.5×+0.1×

Profitability

See full
Gross margin65.5%-1.6pp
Operating margin11.8%-7.2pp
Net margin5.6%-4.8pp
FCF margin13.5%+4.3pp

Returns & leverage

See full
Return on equity2.9%-2.3pp
Debt / equity0.4×+0.1×
Current ratio1.3×-0.8×

Where this comes from

Reported directly by The Cooper Companies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026.

Filed
Jun 5, 2026, 4:47 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-041305
Line item20262025
Repurchase of common stock(108.0)(40.6)
Issuance of common stock for employee stock purchase plan3.94.2
Settlement of contingent consideration(1.3)
Net cash used in financing activities(223.7)(105.2)
Effect of exchange rate changes on cash, cash equivalents and restricted cash1.32.9
Net increase in cash, cash equivalents, and restricted cash28.48.5
Cash, cash equivalents, and restricted cash at beginning of period110.6107.7
Cash, cash equivalents, and restricted cash at end of period$139.0$116.2

Item 1. Unaudited Financial Statements

FAQ

What is The Cooper Companies, Inc.'s financing cash flow?
The Cooper Companies, Inc. (COO) reported financing cash flow of -$75.8M in Q1 2026.
How has The Cooper Companies, Inc.'s financing cash flow changed year-over-year?
The Cooper Companies, Inc.'s financing cash flow decreased by 781.4% year-over-year, from -$8.6M to -$75.8M.
What is the long-term trend for The Cooper Companies, Inc.'s financing cash flow?
Over 2 years (2021 to 2025), The Cooper Companies, Inc.'s financing cash flow has grown at a 16.9% compound annual growth rate (CAGR), from -$311.4M to -$425.9M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about The Cooper Companies, Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude